Daniel P. Petrylak, MD

Daniel P. Petrylak, MD, Professor of Medicine and Urology at the Yale School of Medicine

Articles by Daniel P. Petrylak, MD

Vadim Koshkin, MDRoundtable | July 7, 2023
The panel discusses studies and areas of interest related to treatment options for advanced bladder cancer.
View More
Vadim Koshkin, MDRoundtable | July 7, 2023
The panel discussed how treatments used in the metastatic space are moving into the perioperative setting.
Vadim Koshkin, MDRoundtable | July 7, 2023
The panel discusses the potential for more targeted treatments making their way into the advanced bladder cancer space.
Vadim Koshkin, MDRoundtable | July 7, 2023
The panel addresses treatment sequencing decisions following disease relapse.
Vadim Koshkin, MDRoundtable | August 22, 2023
The panel discusses the approach to treating patients with platinum-ineligible bladder cancer.
Vadim Koshkin, MDUrothelial Carcinoma | July 7, 2023
The panel discusses patient characteristics and treatment sequencing considerations.
Vadim Koshkin, MDRoundtable | July 7, 2023
The panel discusses the approach to treating patients with cisplatin-ineligible bladder cancer.
Vadim Koshkin, MDRoundtable | July 7, 2023
The panel discusses the approach to treating patients with cisplatin-eligible bladder cancer.
Daniel P. Petrylak, MDASCO GU Symposium 2023 | April 3, 2023
Daniel P. Petrylak, MD, overviews the TROPHY-U-01 study for platinum-ineligible patients with metastatic UC.